SCHEMBL5016910

SCHEMBL5016910

Cn1cc(-c2ccc(OCc3ccccc3)cc2)c2c(N)ncnc21

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 1/20 0.65
PIK3CA P42336 1/20 0.65
PIK3CB P42338 1/20 0.65
PIK3CG P48736 1/20 0.65
PRKDC P78527 1/20 0.65
IGF1R P08069 6/20 0.59
INSR P06213 2/20 0.59
SRC P12931 10/20 0.58
KDR P35968 6/20 0.58
ABL1 P00519 5/20 0.58
EGFR P00533 5/20 0.58
ABL2 P42684 4/20 0.58
LCK P06239 5/20 0.56
TEK Q02763 3/20 0.56
BTK Q06187 1/20 0.54
CDK1 P06493 3/20 0.52
RIPK2 O43353 1/20 0.50
AURKA O14965 1/20 0.49
ROCK2 O75116 1/20 0.49
PAK4 O96013 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14050381 0.88 IGF1R (0.72) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL7833880 0.86 SRC (0.75) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL7005521 0.85 LCK (0.72) INSRSRCKDRABL1EGFR
SCHEMBL2073299 0.85 KDR (0.76) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL7847466 0.84 SRC (0.73) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL16202367 0.84 SRC (0.67) SRCKDRABL1EGFRABL2
SCHEMBL22676745 0.81 SRC (0.67) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL27381323 0.80 IGF1R (0.62) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL7835124 0.80 SRC (0.62) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL130425 0.79 PIK3CD (1.00) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230111917-A1 KINASE ANTAGONISTS UNIV CALIFORNIA (US) 2023-04-13 US disclosed
CN-101506211-B Kinase antagonists UNIV CALIFORNIA 2013-05-22 CN disclosed
CN-101506211-A Kinase antagonists UNIV CALIFORNIA (US) 2009-08-12 CN disclosed
EP-2004654-A2 KINASE ANTAGONISTS The Regents of the University of California (US) 2008-12-24 EP disclosed
WO-2007114926-A2 KINASE ANTAGONISTS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2007-10-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230111917-A1 KINASE ANTAGONISTS MTOR, RPS6KA3, AKT3 PIK3CD 12/4885PIK3CA 4/4885PIK3CB 21/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.